Berse, Samuel J.
"The Practical Implications of Association of Molecular Pathology v. Myriad Genetics, Inc. and BRCA1 - & BRCA2 - Based Hereditary Cancer Test Patent Litig. v. Ambry Genetics Corp. on the Biotechnology Industry,"
Seton Hall Journal of Legislation and Public Policy: Vol. 39:
2, Article 7.
Available at: https://scholarship.shu.edu/shlj/vol39/iss2/7